A carregar...
Thrombolytic therapy for pulmonary embolism
BACKGROUND: Thrombolytic therapy is usually reserved for people with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concern...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2021
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092433/ https://ncbi.nlm.nih.gov/pubmed/33857326 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD004437.pub6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|